Gadobutrol (Gadavist/Gadovist, BAY86-4875)

DRUG3 trials

Sponsors

Bayer

Conditions

Contrast Enhancement in Magnetic Resonance ImagingImage EnhancementMagnetic Resonance Imaging

Phase 4

Comparison of Gadovist 75% Standard Dose to Dotarem at Full Standard Dose

CompletedNCT03602339

BayerMagnetic Resonance Imaging

Start: 2018-11-14End: 2020-05-26Updated: 2021-06-14

Unknown Phase

Drug Use Investigation of Gadovist.

CompletedNCT02540967

BayerImage Enhancement, Magnetic Resonance Imaging

Start: 2015-10-27End: 2017-11-02Updated: 2023-11-07

A Study Called GUS to Understand How Much of the Contrast Agent Gadavist is Used and How Much is Wasted in Two Different Containers (Single-dose Vials and Imaging Bulk Packages ) in a Real-world Setting

CompletedNCT05350189

BayerContrast Enhancement in Magnetic Resonance Imaging

Start: 2022-11-03End: 2023-04-27Updated: 2024-04-01

Related Papers

Clinical Efficacy of Reduced-Dose Gadobutrol Versus Standard-Dose Gadoterate for Contrast-Enhanced MRI of the CNS: An International Multicenter Prospective Crossover Trial (LEADER-75)

American Journal of Roentgenology2021-06-1619 citations